References
- Seyyedi F, Kopaei MR, Miraj S. Comparison between vaginal royal jelly and vaginal estrogen effects on quality of life and vaginal atrophy in postmenopausal women: a clinical trial study. Electron Physician. 2016;8(11):3184–3192.
- Poomalar GK, Arounassalame B. The quality of life during and after menopause among rural women. J Clin Diagn Res. 2013;7(1):135–139.
- Shen J, Song N, Williams CJ, et al. Effects of low dose estrogen therapy on the vaginal microbiomes of women with atrophic vaginitis. Sci Rep. 2016;6(1):24380.
- Kagan R, Kellogg-Spadt S, Parish SJ. Practical treatment considerations in the management of genitourinary syndrome of menopause. Drugs Aging. 2019;36(10):897–908.
- Shim S, Park KM, Chung YJ, et al. Updates on therapeutic alternatives for genitourinary syndrome of menopause: hormonal and non-hormonal managements. J Menopausal Med. 2021;27(1):1–7.
- Nappi RE, Palacios S. Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric. 2014;17(1):3–9.
- Scavello I, Maseroli E, Di Stasi V, et al. Sexual health in menopause. Medicina (Kaunas). 2019;55(9):559.
- Briggs P. Genitourinary syndrome of menopause. Post Reprod Health. 2020;26(2):111–114.
- Hocke C, Diaz M, Bernard V, et al. [Genitourinary menopause syndrome. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines]. Gynecol Obstet Fertil Senol. 2021;49(5):394–413.
- Management of symptomatic vulvovaginal atrophy: 2013 position statement of the North American Menopause Society. Menopause (New York, NY). 2013;20(9):888–902. quiz 3-4.
- Simon JA, Reape KZ, Wininger S, et al. Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women. Fertil Steril. 2008;90(4):1132–1138.
- Baber RJ, Panay N, Fenton A, Group IMSW. 2016 IMS recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016;19(2):109–150.
- Faubion SS, Larkin LC, Stuenkel CA, et al. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from the North American Menopause Society and the International Society for the Study of Women’s Sexual Health. Menopause. 2018;25(6):596–608.
- The NGSMPSEP. The 2020 genitourinary syndrome of menopause position statement of the North American Menopause Society. Menopause (New York, NY). 2020;27(9):976–992.
- Suwanvesh N, Manonai J, Sophonsritsuk A, et al. Comparison of Pueraria mirifica gel and conjugated equine estrogen cream effects on vaginal health in postmenopausal women. Menopause (New York, NY). 2017;24(2):210–215.
- Palacios S, Losa F, Dexeus D, et al. Beneficial effects of a Coriolus versicolor-based vaginal gel on cervical epithelization, vaginal microbiota and vaginal health: a pilot study in asymptomatic women. BMC Womens Health. 2017;17(1):21.
- Faubion SS, Sood R, Kapoor E. Genitourinary syndrome of menopause: management strategies for the clinician. Mayo Clin Proc. 2017;92(12):1842–1849.
- Angelou K, Grigoriadis T, Diakosavvas M, et al. The genitourinary syndrome of menopause: an overview of the recent data. Cureus. 2020;12(4):e7586.
- Nappi RE, Martini E, Cucinella L, et al. Addressing vulvovaginal atrophy (VVA)/genitourinary syndrome of menopause (GSM) for healthy aging in women. Front Endocrinol (Lausanne). 2019;10:561.
- Bachmann G, Bouchard C, Hoppe D, et al. Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally. Menopause (New York, NY). 2009;16(4):719–727.
- Lethaby A, Ayeleke RO, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2016;2016(8):CD001500.
- Hodis HN, Mack WJ, Henderson VW, et al. Vascular effects of early versus late postmenopausal treatment with estradiol. N Engl J Med. 2016;374(13):1221–1231.
- Hawkes N. HRT increases risk of blood clots and stroke, finds new analysis. BMJ. 2015;350:h1336.
- Dennerstein L, Dudley EC, Hopper JL, et al. A prospective population-based study of menopausal symptoms. Obstet Gynecol. 2000;96(3):351–358.
- Perez-Lopez FR, Vieira-Baptista P, Phillips N, et al. Clinical manifestations and evaluation of. Postmenopausal vulvovaginal atrophy. Gynecol Endocrinol. 2021;37(8):740–745.
- Samsioe G. Urogenital aging–a hidden problem. Am J Obstet Gynecol. 1998;178(5):S245–S9.
- Bachmann GA, Nevadunsky NS. Diagnosis and treatment of atrophic vaginitis. Am Fam Physician. 2000;61(10):3090–3096.
- Carcio H. Urogenital atrophy. A new approach to vaginitis diagnosis. Adv Nurse Pract. 2002;10(10):40–48, 51.